Aartech Solonics (AARTECH)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Low debt/equity of 0.16 provides financial flexibility
• Promoter holding of 52.75% aligns promoter interests with minority shareholders
• Latest quarter is net positive with ₹7 Cr sales and ₹1 Cr profit
• Company remains profitable despite recent sales pressure

Concerns

• P/E of 42.09 and P/B of 5.04 are expensive relative to ROE of 0.88% and ROCE of 5.64%
• Sales declined 24.54% and profits fell 3.23%
• Piotroski F-Score of 3/9 indicates weak financial health
• Dividend yield of 0.29% offers negligible income support

AI Analysis

As a value investor, I begin with the business, not the ticker. Aartech Solonics operates in heavy electrical equipment, an area where I can understand the demand, but understanding does not equal a margin of safety. At ₹50.24, the market cap is ₹136 Cr. I am being asked to pay 42.09 times earnings and 5.04 times book value, while book value stands at just ₹9.97 per share. That is an expensive price unless the company can compound capital at a high rate. The reported numbers say otherwise: ROE is only 0.88%, and ROCE is 5.64%. Sales have fallen 24.54%, and profits have declined 3.23%. A latest quarter with ₹7 Cr sales and ₹1 Cr net profit is positive, but one quarter does not rebuild a weak earnings trajectory. The Piotroski F-Score of 3/9 reinforces my worry: this is a poor fundamental score, suggesting deteriorating financial health. There are some good signs. Debt/equity is low at 0.16, and promoters hold 52.75%, so their interests are aligned with mine. But prudent financing and ownership alignment are not enough. The dividend yield is a token 0.29%, leaving little income return. In Graham's language, price is what you pay, value is what you get. At 42 times earnings and 5 times book for a business earning less than 1% on equity, I do not get a margin of safety. This is not a Stalwart or a Fast Grower. It may be a turnaround candidate if operations stabilise, but I need evidence, not hope. I want to see rising sales, higher ROE, better capital utilisation, and a clear path to earnings growth before I commit capital. Until then, this belongs on the watchlist, not in the portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer